{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:22:20Z","timestamp":1761934940185,"version":"build-2065373602"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,6,21]],"date-time":"2004-06-21T00:00:00Z","timestamp":1087776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Compliance studies have shown that patients with reflux symptoms generally take their medication only when experiencing these symptoms.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate the efficacy of on\u2010demand rabeprazole maintenance therapy in patients with non\u2010erosive reflux disease.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002This multicentre, randomized, double\u2010blind, placebo\u2010controlled, withdrawal study compared 6\u2003months of on\u2010demand treatment with rabeprazole 10\u2003mg vs. placebo. Adults with a history of reflux symptoms, a negative endoscopy, and \u22653\u2003days of moderate to very severe heartburn in the 7\u2003days before enrolment (<jats:italic>N<\/jats:italic>\u2003=\u2003535) entered 4\u2003weeks of open\u2010label, acute treatment with rabeprazole 10\u2003mg once daily. Patients with complete symptom relief then entered the on\u2010demand phase. The primary end\u2010point was discontinuation due to lack of heartburn control during the on\u2010demand phase.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Eighty\u2010three percent (432 of 523) of patients reported complete symptom relief at the end of the acute phase. During on\u2010demand treatment, rates of discontinuation because of inadequate heartburn control were 20% (28 of 139) for placebo vs. 6% (16 of 279) for rabeprazole (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.00001). Antacid use was twofold higher in the placebo group vs. the rabeprazole group (<jats:italic>P<\/jats:italic>\u2003=\u20030.0009).<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Rabeprazole 10\u2003mg once daily is highly effective in acute symptom relief and as on\u2010demand long\u2010term maintenance therapy in non\u2010erosive reflux disease patients.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.01999.x","type":"journal-article","created":{"date-parts":[[2004,7,5]],"date-time":"2004-07-05T19:11:09Z","timestamp":1089054669000},"page":"181-188","source":"Crossref","is-referenced-by-count":68,"title":["Six\u2010month trial of on\u2010demand rabeprazole 10\u2003mg maintains symptom relief in patients with non\u2010erosive reflux disease"],"prefix":"10.1111","volume":"20","author":[{"given":"P.","family":"Bytzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"De Herdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the trial investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,6,21]]},"reference":[{"key":"e_1_2_22_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03511.x"},{"key":"e_1_2_22_3_2","first-page":"463","article-title":"Factors influencing compliance in long\u2010term proton pump inhibitor therapy in general practice","volume":"49","author":"Hungin APS","year":"1999","journal-title":"Br J Gen Pract"},{"key":"e_1_2_22_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00564.x"},{"key":"e_1_2_22_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1803"},{"key":"e_1_2_22_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01759.x"},{"key":"e_1_2_22_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)00013-3"},{"key":"e_1_2_22_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.36.22438"},{"key":"e_1_2_22_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00418.x"},{"key":"e_1_2_22_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01292.x"},{"key":"e_1_2_22_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01573.x"},{"key":"e_1_2_22_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01496.x"},{"key":"e_1_2_22_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01181.x"},{"key":"e_1_2_22_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05769.x"},{"key":"e_1_2_22_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609095544"},{"key":"e_1_2_22_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00943.x"},{"key":"e_1_2_22_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200208000-00008"},{"key":"e_1_2_22_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011211"},{"key":"e_1_2_22_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.8.845"},{"key":"e_1_2_22_20_2","first-page":"37","article-title":"Natural course of gastroesophageal reflux disease: 17\u201322\u2010year follow\u2010up of 60 patients","volume":"92","author":"Isolauri J","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_22_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018822532736"},{"key":"e_1_2_22_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00438.x"},{"key":"e_1_2_22_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200453566"},{"key":"e_1_2_22_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00035.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01999.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01999.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.01999.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:18:54Z","timestamp":1697231934000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.01999.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,21]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1365-2036.2004.01999.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.01999.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"type":"print","value":"0269-2813"},{"type":"electronic","value":"1365-2036"}],"subject":[],"published":{"date-parts":[[2004,6,21]]}}}